Blockchain Registration Transaction Record

GeoVax Advances Domestic Vaccine Capability to Strengthen America's Biosecurity

GeoVax Labs, Inc. highlights its commitment to reinforcing America's biosecurity through the development of the GEO-MVA vaccine, addressing critical vulnerabilities in the U.S. vaccine supply and national preparedness. The company's efforts to enhance domestic vaccine production align with national initiatives to strengthen U.S. biomanufacturing resilience and achieve vaccine independence.

GeoVax's commitment to domestic vaccine production and the development of the GEO-MVA vaccine not only addresses critical vulnerabilities in the U.S. vaccine supply but also supports national initiatives to enhance biomanufacturing resilience. By reducing reliance on foreign manufacturers and bolstering domestic biosecurity, GeoVax's efforts contribute to achieving vaccine independence and improving public health preparedness.